Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gene therapy for ALS: A review
Defne A. Amado, Beverly L. Davidson
Molecular Therapy (2021) Vol. 29, Iss. 12, pp. 3345-3358
Open Access | Times Cited: 135

Showing 1-25 of 135 citing articles:

Amyotrophic lateral sclerosis
Eva L. Feldman, Stephen A. Goutman, Susanne Petri, et al.
The Lancet (2022) Vol. 400, Iss. 10360, pp. 1363-1380
Open Access | Times Cited: 533
Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis
Stephen A. Goutman, Orla Hardiman, Ammar Al‐Chalabi, et al.
The Lancet Neurology (2022) Vol. 21, Iss. 5, pp. 465-479
Open Access | Times Cited: 248
Clinical implementation of RNA sequencing for Mendelian disease diagnostics
Vicente A. Yépez, Mirjana Gušić, Robert Kopajtich, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 140
SOD1 mutations associated with amyotrophic lateral sclerosis analysis of variant severity
Mariusz Berdyński, Przemysław Miszta, Krzysztof Safranow, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 113
Hydrocephalus: historical analysis and considerations for treatment
Alexandra Hochstetler, Jeffrey S. Raskin, Bonnie L. Blazer‐Yost
European journal of medical research (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 103
Genetics of amyotrophic lateral sclerosis: seeking therapeutic targets in the era of gene therapy
Naoki Suzuki, Ayumi Nishiyama, Hitoshi Warita, et al.
Journal of Human Genetics (2022) Vol. 68, Iss. 3, pp. 131-152
Open Access | Times Cited: 93
AAV vectors applied to the treatment of CNS disorders: Clinical status and challenges
Lin Kang, Shilin Jin, Jiayi Wang, et al.
Journal of Controlled Release (2023) Vol. 355, pp. 458-473
Open Access | Times Cited: 61
Current State and Future Directions in the Therapy of ALS
Laura Tzeplaeff, Sibylle Wilfling, Maria Viktoria Requardt, et al.
Cells (2023) Vol. 12, Iss. 11, pp. 1523-1523
Open Access | Times Cited: 55
Advancements in genetic research and RNA therapy strategies for amyotrophic lateral sclerosis (ALS): current progress and future prospects
Paola Ruffo, Bryan J. Traynor, F. L. Conforti
Journal of Neurology (2025) Vol. 272, Iss. 3
Open Access | Times Cited: 2
Current and Future Prospects for Gene Therapy for Rare Genetic Diseases Affecting the Brain and Spinal Cord
Thomas Leth Jensen, Casper R. Gøtzsche, David P.D. Woldbye
Frontiers in Molecular Neuroscience (2021) Vol. 14
Open Access | Times Cited: 60
The Biogenesis of miRNAs and Their Role in the Development of Amyotrophic Lateral Sclerosis
Jinmeng Liu, Fenghua Zhou, Yingjun Guan, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 572-572
Open Access | Times Cited: 39
Research Status and Prospect of Non-Viral Vectors Based on siRNA: A Review
Liangnan Tong, Danqing Liu, Zhiyue Cao, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3375-3375
Open Access | Times Cited: 30
Current State and Future Directions in the Diagnosis of Amyotrophic Lateral Sclerosis
Maximilian Vidovic, Lars Hendrik Müschen, Svenja Brakemeier, et al.
Cells (2023) Vol. 12, Iss. 5, pp. 736-736
Open Access | Times Cited: 25
Limbic-predominant age-related TDP43 encephalopathy (LATE) neuropathological change in neurodegenerative diseases
Sukriti Nag, Julie A. Schneider
Nature Reviews Neurology (2023) Vol. 19, Iss. 9, pp. 525-541
Closed Access | Times Cited: 24
At-home wearables and machine learning sensitively capture disease progression in amyotrophic lateral sclerosis
Anoopum S. Gupta, Siddharth Patel, Alan Premasiri, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 24
Opinion: more mouse models and more translation needed for ALS
Elizabeth Fisher, Linda Greensmith, Andrea Malaspina, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 23
Role and therapeutic targets of P2X7 receptors in neurodegenerative diseases
Huiyong Zheng, Qiang Liu, Siwei Zhou, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Regulation of mitophagy and mitochondrial function: Natural compounds as potential therapeutic strategies for Parkinson's disease
Hao Liang, Zhenwang Ma, Wei Zhong, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 4, pp. 1838-1862
Open Access | Times Cited: 8
Application of antisense oligonucleotide drugs in amyotrophic lateral sclerosis and Huntington’s disease
Kaili Ou, Qingqing Jia, Dandan Li, et al.
Translational Neurodegeneration (2025) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Gene Therapy in ALS and SMA: Advances, Challenges and Perspectives
Jan Lejman, Kinga Panuciak, Emilia Nowicka, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1130-1130
Open Access | Times Cited: 22
Roadmap for C9ORF72 in Frontotemporal Dementia and Amyotrophic Lateral Sclerosis: Report on the C9ORF72 FTD/ALS Summit
Rita Sattler, Bryan J. Traynor, Janice Robertson, et al.
Neurology and Therapy (2023) Vol. 12, Iss. 6, pp. 1821-1843
Open Access | Times Cited: 21
Congenital hydrocephalus: a review of recent advances in genetic etiology and molecular mechanisms
Xiuyun Liu, Xin Song, Marek Czosnyka, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 6
Insights into the identification of a molecular signature for amyotrophic lateral sclerosis exploiting integrated microRNA profiling of iPSC-derived motor neurons and exosomes
Mafalda Rizzuti, Valentina Melzi, Delia Gagliardi, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 3
Open Access | Times Cited: 24
Time for optimism in amyotrophic lateral sclerosis
Philippe Corcia, Christian Lunetta, Patrick Vourc’h, et al.
European Journal of Neurology (2023) Vol. 30, Iss. 5, pp. 1459-1464
Open Access | Times Cited: 14
STAT6-targeting antisense oligonucleotides against solitary fibrous tumor
Yi Li, José L. Mondaza-Hernández, David S. Moura, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 2, pp. 102154-102154
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top